Scynexis (SCYX) Other Accumulated Expenses (2016 - 2026)
Scynexis (SCYX) posted Other Accumulated Expenses of $809000.0 for Q1 2026, up 69.25% on a QoQ basis from $478000.0 in Q4 2025, and down 14.12% year-over-year from $942000.0 in Q1 2025.
Scynexis (SCYX) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
Scynexis' Other Accumulated Expenses history runs 11 years deep, the most recent figure standing at $809000.0 for Q1 2026.
- Quarterly Other Accumulated Expenses fell 14.12% year-over-year to $809000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $809000.0 (down 14.12% YoY) and the FY2025 annual result came in at $478000.0, down 39.34% from the prior year.
- Other Accumulated Expenses was $809000.0 for Q1 2026 at Scynexis, up from $478000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $2.2 million in Q2 2022 and bottomed at $478000.0 in Q4 2025.
- A 5-year average of $1.1 million and a median of $895000.0 in 2025 frame the typical range for Other Accumulated Expenses.
- Peak annual rise in Other Accumulated Expenses reached 79.6% in 2022, while the deepest fall reached 66.45% in 2022.
- Scynexis' Other Accumulated Expenses stood at $1.3 million in 2022, then dropped by 20.79% to $1.0 million in 2023, then decreased by 24.23% to $788000.0 in 2024, then tumbled by 39.34% to $478000.0 in 2025, then soared by 69.25% to $809000.0 in 2026.
- Business Quant data shows SCYX's Other Accumulated Expenses at $809000.0 in Q1 2026, $478000.0 in Q4 2025, and $895000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 809,000.00 |
| Dec 31, 2025 | 478,000.00 |
| Sep 30, 2025 | 895,000.00 |
| Jun 30, 2025 | 757,000.00 |
| Mar 31, 2025 | 942,000.00 |
| Dec 31, 2024 | 788,000.00 |
| Sep 30, 2024 | 969,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Mar 31, 2024 | 546,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 720,000.00 |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 1.89 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 2.15 Mn |
| Jun 30, 2021 | 1.39 Mn |
| Mar 31, 2021 | 1.05 Mn |
| Dec 31, 2020 | 960,000.00 |